IMMODULON THERAPEUTICS LIMITED

Dissolved London
4 employees website.com
Life sciences and medical technology
I

IMMODULON THERAPEUTICS LIMITED

Founded 23 Apr 2007 Dissolved London, United Kingdom 4 employees website.com
Life sciences and medical technology
Accounts Due 31 Dec 2024 18 months overdue
Confirmation
Net assets £2M £103K 2022 year on year
Total assets £3M £418K 2022 year on year
Total Liabilities £1M £521K 2022 year on year
Charges 4
4 outstanding

Contact & Details

Contact

Registered Address

C/O Quantuma Advisory Limited 7th Floor 20 St. Andrew Street London EC4A 3AG

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for IMMODULON THERAPEUTICS LIMITED (06223291), a dissolved life sciences and medical technology company based in London, United Kingdom. Incorporated 23 Apr 2007. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type total-exemption-full
Next accounts 31 Dec 2023
Due by 31 Dec 2024 18 months overdue

Net Assets, Total Assets & Total Liabilities (2014–2022)

Cash in Bank

£1.71M

Decreased by £171.29k (-9%)

Net Assets

£1.82M

Increased by £103.30k (+6%)

Total Liabilities

£1.00M

Decreased by £520.84k (-34%)

Turnover

N/A

Employees

4

Decreased by 2 (-33%)

Debt Ratio

35%

Decreased by 12 (-26%)

Financial History

Revenue, profit, EBITDA and key financial figures

2022
31 Dec Year End
2021
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

12 Allotments 40,604 Shares £6.45m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 May 20224,545£500k£110.011
18 Oct 20213,030£500k£165.017
21 Sept 20213,030£500k£165.017
21 Jul 20213,030£500k£165.017
21 Jul 20211,516£250k£164.908

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (26)

Lifexx Sa
27.5%
Anthony John Bolton
15.7%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Lifexx Sa

Switzerland

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

IMMODULON THERAPEUTICS LIMITED Current Company

Charges

Charges

4 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
28 Apr 2026OfficersTermination of Joseph Oliver Mason as director on 14 Apr 2026
7 Aug 2025InsolvencyLiquidation In Administration Extension Of Period
16 Jul 2025InsolvencyLiquidation In Administration Progress Report
11 Mar 2025MortgageMortgage Charge Part Both With Charge Number
11 Mar 2025MortgageMortgage Charge Part Both With Charge Number
28 Apr 2026 Officers

Termination of Joseph Oliver Mason as director on 14 Apr 2026

7 Aug 2025 Insolvency

Liquidation In Administration Extension Of Period

16 Jul 2025 Insolvency

Liquidation In Administration Progress Report

11 Mar 2025 Mortgage

Mortgage Charge Part Both With Charge Number

11 Mar 2025 Mortgage

Mortgage Charge Part Both With Charge Number

Recent Activity

Latest Activity

Termination of Joseph Oliver Mason as director on 14 Apr 2026

1 months ago on 28 Apr 2026

Liquidation In Administration Extension Of Period

10 months ago on 7 Aug 2025

Liquidation In Administration Progress Report

10 months ago on 16 Jul 2025

Mortgage Charge Part Both With Charge Number

1 years ago on 11 Mar 2025

Mortgage Charge Part Both With Charge Number

1 years ago on 11 Mar 2025